Great Lakes Advisors LLC Invests $9.76 Million in Danaher Corporation $DHR

Key Points

• Great Lakes Advisors acquired a new $9.76 million stake in Danaher during the second quarter, purchasing 13,556 shares. Institutional investors collectively own 79.05% of the company.
• Analysts maintain a “Moderate Buy” consensus rating, with an average price target of $228.91, despite several recent target reductions and one downgrade to “peer perform.”
• Danaher exceeded quarterly expectations, reporting $1.94 in EPS and $6.26 billion in revenue, with revenue up 5.5% year over year. The stock opened at $211.92 and was reported to be trading 6.2% higher.

Great Lakes Advisors LLC acquired a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 13,556 shares of the conglomerate's stock, valued at approximately $9,761,000.

Several other hedge funds also recently bought and sold shares of the company. Main Street Group LTD purchased a new stake in Danaher in the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the second quarter worth $25,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter worth $25,000. WFA of San Diego LLC bought a new stake in Danaher during the second quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter worth about $27,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent analyst reports. Morgan Stanley lowered their price target on Danaher from $270.00 to $255.00 and set an "overweight" rating on the stock in a report on Wednesday, April 22nd. Argus decreased their price objective on shares of Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research report on Friday, April 24th. UBS Group lowered their target price on shares of Danaher from $270.00 to $250.00 and set a "buy" rating on the stock in a research note on Wednesday, April 22nd. Wolfe Research lowered shares of Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Finally, Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $228.91.

Danaher Trading Up 6.2%

NYSE DHR opened at $211.92 on Thursday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock's 50-day simple moving average is $194.30 and its two-hundred day simple moving average is $192.44. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market capitalization of $148.98 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 2.49 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.77 EPS. Research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source